Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis

BACKGROUND: Borderline personality disorder (BPD) is a debilitating psychiatric disorder that affects 0.4–3.9% of the population in Western countries. Currently, no medications have been approved by regulatory agencies for the treatment of BPD. Nevertheless, up to 96% of patients with BPD receive at...

Descripción completa

Detalles Bibliográficos
Autores principales: Gartlehner, Gerald, Crotty, Karen, Kennedy, Sara, Edlund, Mark J., Ali, Rania, Siddiqui, Mariam, Fortman, Robyn, Wines, Roberta, Persad, Emma, Viswanathan, Meera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478737/
https://www.ncbi.nlm.nih.gov/pubmed/34495494
http://dx.doi.org/10.1007/s40263-021-00855-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478737/
https://www.ncbi.nlm.nih.gov/pubmed/34495494
http://dx.doi.org/10.1007/s40263-021-00855-4

Ejemplares similares